Academic Staff

Education Background:

• B.Sc. in Pharm (Chulalongkorn University, Thailand)
• Doctor of Pharmacy (University of Illinois at Chicago, USA)
• Certified Pharmacy Practice Resident (University of Illinois at Chicago, USA)
• Certified Pediatric Pharmacy Resident (University of Illinois at Chicago, USA)
• Board certified pharmacotherapy specialist (Board of Pharmaceutical Specialty, USA)
• Board certified pharmacotherapy (Pharmacy council, Thailand)

Work Experience:

• Associate Professor at the Department of Pharmacy, Faculty of Pharmacy, Mahidol University, 2014-present
• Assistant Professor at the Department of Pharmacy, Faculty of Pharmacy, Mahidol University, 2001-2014
• Lecturer at the Department of Pharmacy, Faculty of Pharmacy, Mahidol University, 1994-2001
• Pharmacist at Senangkhanikhom Hospital, Amnat Charoen, 1991-1993

Expertise:

• Antibiotic Stewardship
• Monte Carlo Simulation
• Pharmacokinetic and pharmacodynamic properties of anti-infective agents
• Pharmaceutical care

Current Research:

1. Thirapanmethee K, Srisiri-A-Nun T, Houngsaitong J, Montakantikul P, Khuntayaporn P, Chomnawang MT. Prevalence of OXA-Type β-Lactamase Genes among Carbapenem-Resistant Acinetobacter baumannii Clinical Isolates in Thailand. Antibiotics (Basel). 2020 Dec 3;9(12):E864. doi: 10.3390/antibiotics9120864.
2. Houngsaitong J, Montakantikul P, Paiboonwong1 T, Chomnawang M, Khuntayaporn P, Chulavatnatol S. In vitro activity of biapenem and comparators against multidrug-resistant and carbapenem-resistant Acinetobacter baumannii isolated from tertiary care hospitals in Thailand. Pharm Sci Asia 2020; 47(4), 378-386. DOI: 10.29090/psa.2020.04.019.0072
3. Leelawatanachai P, Wattanavijitkul T, Paiboonvong T, Plongla R , Chatsuwan T, Usayaporn S, Nosoongnoen W, Montakantikul P.Evaluation of Intravenous Fosfomycin Disodium Dosing Regimens in Critically Ill Patients for Treatment of Carbapenem-Resistant Enterobacterales Infections Using Monte Carlo Simulation. Antibiotics 2020, 9, 615; doi:10.3390/antibiotics9090615.
4. Khan-asa B, Punyawudho B, Singkham N, Chaivichacharn P, Karoopongse E, Chayakulkeeree M, Montakantikul P. Impact of Albumin and Omeprazole on Steady-State Population Pharmacokinetics of Voriconazole and Development of a Voriconazole Dosing Optimization Model in Thai Patients with Hematologic Diseases. Antibiotics 2020: 9, 574; doi:10.3390/antibiotics9090574www.mdpi.com.
5. Surapat, B., Montakantikul, P., Malathum, K. et al. Microbial epidemiology and risk factors for relapse in gram-negative bacteria catheter-related bloodstream infection with a pilot prospective study in patients with catheter removal receiving short-duration of antibiotic therapy. BMC Infect Dis 20, 604 (2020). https://doi.org/10.1186/s12879-020-05312-z
6. Rodjun V, Houngsaitong J, Montakantikul P, Paiboonvong T, Khuntayaporn P, Yanyongchaikit P, Sriyant P. In Vitro Activities of Colistin and Sitafloxacin Combinations against Multidrug-, Carbapenem-, and Colistin-Resistant Acinetobacter baumannii Using the Broth Microdilution Checkerboard and Time-Kill Methods. Antibiotics 2020;9:516; doi:10.3390/antibiotics9080516.
7. Lertwattanachai T, Montakantikul P, Tangsujaritvijit V, Sanguanwit P, Sueajai J, Auparakkitanon S, Dilokpattanamongkol P. Clinical outcomes of empirical high dose meorpenem in critically ill patients with sepsis and septic shock: a randomized controlled trial. J Intensive Care 2020:8:26:1-10.
8. Paiboonvong T, Rodjun V, Houngsaitong J, Chomnawang M, Montakantikul P, Chulavatnatol S. Comparative in vitro activity of sitafloxacin against multidrug-resistant and carbapenem-resistant Acinetobacter baumannii clinical isolates in Thailand. Pharm Sci Asia 2020;47:37-42.
9. Jitaree K, Sathirakul K, Houngsaitong J, Asuphon O, Saelim W, Thamlikitkul V, Montakantikul P. Pharmacokinetic/Pharmacodynamic (PK/PD) simulation for dosage optimization of colistin against Carbapenem-Resistant Klebsiella pneumoniae  and Carbapenem-Resistant Escherichia coli . Antibiotics 2019;8(3):125; https://doi.org/10.3390/antibiotics8030125 .
10. Paiboonvong T,  Nosoongnoen W, Sathirakul K, Tangsujaritvijit V, Kaemapairoj J, Tragulpiankit P, Montakantikul P. Pharmacokinetics and Penetration of Sitafloxacin into Alveolar Epithelial Lining Fluid in Thai Critically Ill Patients with Pneumonia. Antimicrob Agents Chemother 2019:63(10):e00800-19. DOI: 10.1128/AAC.00800-19
11. So-ngern A, Leelasupasri S, Chulavatnatol S, Pummangura C, Bunupuradah P, Montakantikul P. Prognosis Value of Serum Procalcitonin for Diagnosis of Bacterial Infections in Critically ill Patients. Infect Chemother  2019;51(3):263-73.
12. Setiawan E, Suwannoi L, Montakantikul P, Chindavijak B. Optimization of Intermittent Vancomycin Dosage Regimens for Thai Critically Ill Population Infected by MRSA in the Era of the “MIC Creep” Phenomenon. Act Medica Indonesiana 2019;51(1):10-8.
13. Choorassamee J, Sonthisombat P, Kiraatisin P, Montakantikul P. Pharmacodynamic-based dosage regimens for imipenem meropenem and doripenem to treat melioidosis: a Monte Carlo Simulation. Southeast  Asian  J  Trop Med Public Health 2019;50(2):275-82.
14. Leelawattanachai P, Montakantikul P, Nosoongnoen W, Chayakulkeeree M. Pharmacokinetic/pharmacodynamic study of posaconazole delayed-release tablet in a patient with coexisting invasive aspergillosis and mucormycosis. Ther Clin Risk Manag 2019;15:589-95.
15. Prakobsrikul N, Malathum K, Santanirand P, Chumnumwat S, Piebpien P, Montakantikul P. Correlation between antimicrobial consumption and the prevalence of carbapenem-resistant Escherichia coli and carbapenem-resistant Klebsiella pneumoniae at a University Hospital, Thailand. J Clin Pharm Ther 2019 Apr;44(2):292-299.
16. Bubpamala J, Khuntayaporn P, Thirapanmethee K, Montakantikul P, Santanirand P, Chomnawanf MT. Phenotypic and genotypic characterizations of extended-spectrum beta-lactamase-producing Escherichia coli in Thailand. Infection and Drug Resistance 2018;11: 2151–7.
17. Setiasuwan E, Montakantikul P. Pharmacokinetic and Pharmacodynamic Approach in Adult Critically-Ill Patients Treated with Standard Dose of Vancomycin for MRSA Infection. J Med Assoc Thai 2018;101(5):1-9.
18. Paiboonvong T, Pummangura C, Tedtaisong P, Thamlikitkul V, Tragulpiankit P, Suansanae T, Sukka S, Montakantikul P. Education on antimicrobials, antimicrobial resistance, and infectious diseases in pharmacy curricula, Thailand. Pharm Sci Asia 2018; 45 (2), 105-13.
19. Jannual S, Montakantikul P, Huangsaitong J, Thamalikitkul V, Sonthisombat P. Pharmacodynamic Evaluation of Oral Amoxicillin, Amoxicillin/Clavulanate, Cefditoren, and Azithromycin Against Streptococcus pneumoniae-Caused Respiratory Tract Infections: A Monte Carlo Simulation. J Med Assoc Thai 2018;101(3):305-12.
20. Songern A, Khan-asa B, Montakantikul P, Manosuthi W. Dyslipidemia among Thai HIV-infected  adults receiving antiretroviral therapy: one hospital-based report. Southeast Asian J Trop Med Public Health 2018;49(1):1-8.
21. Dilokpattanamongkol P , Chumnumwat S , Takultacha S ,  Songsomboon S , Montakarntikul P , Lekpittaya N, Sa-ngasoongsong P, Sumritpradit P. Guideline Concordance Evaluation of Antimicrobial Usage in Surgical Patients at University Hospital, Thailand. J Med Assoc Thai 2017; 100 (11):32.
22. Sukkha S, Chindavijak B, Montakantikul P, Ingsathit A, Nosoongnoen W, Sumethkul V. Trough level from twice daily to once daily tacrolimus in early conversion kidney transplant recipients: a prospective study. Int J Clin Pharm. 2017 Dec;39(6):1298-1303.
23. Asuphon O, Montakantikul P, Houngsaitong J, Kiratisin P, Sonthisombat P. Optimizing intravenous fosfomycin dosing in combination with carbapenems for treatment of Pseudomonas aeruginosa infections in critically ill patients based on pharmacokinetic/pharmacodynamic (PK/PD) simulation. Int J Infect Dis 2016; 50:23-9.
24. Montakantikul P, Puttipokin K, Watcharananan SP, Chulavatanatol C. Safety profile of voriconazole in Thai patients: A retrospective, descriptive Study. Songkla Med J 2015;33(3):153-63.
25. Kunakonvichaya B, Thirapanmethee K, Khuntayaporn P, Montakantikul P, Chomnawang MT. Synergistic effects of fosfomycin and carbapenems against carbapenem-resistant Pseudomonas aeruginosa clinical isolates. Int J Antimicrob Agents 2015 May;45(5):556-7.
26. Kristina SA, Thavorncharoensap M, Pongcharoensuk P, Montakantikul P, Suansanae T, Prabandari YS. Effectiveness of tobacco education for pharmacy students in Indonesia. Asian Pac J Cancer Prev. 2014;15(24):10783-6.
27. So-Ngern A, Montakantikul P, Manosuthi W. Clinically significant drug interactions among HIV-infected patients receiving antiretroviral therapy. Southeast Asian J Trop Med Public Health 2014;45(5):1023-31.
28. Khuntayaporn P, Montakantikul P, Santanirand P, Kiratisin P, Chomnawang MT. Molecular investigation of carbapenem resistance among multidrug-resistant Pseudomonas aeruginosa isolated clinically in Thailand. Microbiol Immunol 2013; 57 (10):170-8.
29. Khuntayaporn P, Montakantikul P, Mootsikapun P, Thamlikitkul V,  Chomnawang MT. Prevalence and genotypic relatedness of carbapenem resistance among multidrug-resistant P. aeruginosa in tertiary hospitals across Thailand. Ann Clin  Microbiol Antimicrob 2012;11:25.
30. Monmaturapoj T, Montakantikul P, Mootsikapun P, Tragulpiankit P. A prospective, randomized, double dummy, placebo-controlled trial of oral cefditoren pivoxil 400 mg once daily as switch therapy after intravenous ceftriaxone in the treatment of acute pyelonephritis. Int J Infect Dis 2012; 16: e843-e849.
31. Bhumibhamon N, Montakantikul P, Sangtawesin V, Suksomboon N. Study of  medication reconciliation process in pediatrics medical wards at Queen Sirikit National Institute of Child Health. Thai Pediatr J 2012; 19(1): 23-9.
32. Tragulpiankit P, Montakatikul P, Chulavatnatol S, Chansirikanrnjana S, Thawinwang A. Measured versus estimated creatinine clearance in elderly patients. J App Ther Res 2011:8(2):43-51.
33. Robert JA, Kwa A, Montakantikul P, Gomersall C, Kuti JL, Nicolau DP. Pharmacodynamic profiling of intravenous antibiotics against prevalent gram-negative organisms across the globe: the PASSPAORT program-Asia-Pacific-region. Int J Antimicrob Agents 2011;37:225-9.
34. Chindavijak B, KomindrS, Ritsri W, Montakantikul P.  Effects of changes in patients’ nutritional status upon complications, clinical outcomes, length of hospital stay and hospital expense. Thai Journal of Clinical Nutrition 2009; 3(2): 81-5.
35. Paiboonvong T, Montakantikul P, Chansirikarnjana S, Tragulpiankit P.  Incidence of Medication Errors in Medication Reconciliation at General Medical Wards, Ramathibodi Hospital. Mahidol University J Pharm Sci 2009; 36 (1-4), 44-9.
36. Piebpien P, Tragulpiankit P, Preutthipan A, Montakantikul P. Drug Therapy Problem Management by Pharmacist in Paediatric Intensive Care Unit at a Large Teaching Hospital, Thailand. Drug Safety 2007;30(10):949.
37. Kraitep T, Chulavatnatol S, Montakantikul P, Srisan P, Lochindarat S. Role of Pharmacist in clinical pharmacy services in pediatric intensive care unit at Queen Sirikit National Institute of Child Health. Thai Pediatr J 2006;13(2):176-9.
38. Tragulpiankit P, Pummangura C, Luscombe DK, Kaojarern S, Wananukul W, Montakantikul P, Nathisuwan S. Prevention of adverse drug reactions in hospitalised patients by pharmacist participation at a large teaching hospital in Thailand. Drug Safety 2005;28(10):931.
39. Sangsiri S, Tengapichat W, Bunnag P, Montakantikul P, Suksomboon N. Epidemiology of antidiabetic drug therapy in type 2 diabetes. J Med Tech Assoc Thai  2005;33(3):1271-80.
40. Pummangura C, Tragulpiankit P, Kaojarern S, Wananukul W, Montakantikul P, Luscombe DK, Pomyen N. Characteristics of adverse drug reactions and patient at risk in medical wards. Pharmacy World & Science 2004;26:A100.
41. มนทรัตม์ ถาวรเจริญทรัพย์ ปรีชา มนทกานติกุล พัชราภรณ์ เยี่ยมสวัสดิ์ วีนัส ขุติมานิตสกุล. การสำรวจการยอมรับและความคิดเห็นของเภสัชกรต่อการศึกษาต่อเนื่องทางเภสัชศาสตร์.วารสารเภสัชกรรมโรงพยาบาล 2547; 14(3): 225-233.
42. Prathanturaruk S, Korsanan S, Montakantikul P, Tawapunkul N, Pajongruk M. Counseling for herbal products by community pharmacists. J Health Sci 2004;13:804-12. (Thai version).
43. Suksomboon N, Petchudomsinsuk W, Montakantikul P, Lerdluedeeporn P.  Impact of Pharmacist Intervention in Pediatric Asthma Patients: A Randomised Controlled Trial.  Mahidol J Pharm Sci 2003;30(2):11-16.
44. Pummangura C, Tragulpiankit P, Kaojaroen S, Wananukul W, Montakantikul P, Luscombe DK, Pomyen N. Characteristics of adverse drug reactions and patients at risk in medical wards, Ramathibodi Hospital. Mahidol University Journal of Pharmaceutical Sciences 2003;30(3):25-31.
45. Montakantikul P , Srivilaicharoeng A, Surametheekul S, Kumnunsap S, Reungchareungrung K. Preliminary report of risk factors associated nephrotoxicity from aminoglycosides. Thai J Hosp Pharm 2000;10(4):188-99. (Thai version).

Award & Honor:

Outstanding Lecturer, Mahidol University, 2010